Lawrence M. Alleva - Apr 1, 2024 Form 4 Insider Report for Mersana Therapeutics, Inc. (MRSN)

Role: Director
Signature: /s/ Alejandra Carvajal, Attorney-in-Fact
Stock symbol: MRSN
Transactions as of: Apr 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 4/3/2024, 08:14 PM
Previous filing: Jan 4, 2024
Next filing: Jun 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRSN	Stock Option (right to buy)	Award	$0	+4K		$0.00	4K	Apr 1, 2024	Common Stock	4K	$4.42	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option was granted in connection with the Reporting Person's election to receive the Reporting Person's quarterly retainer for director services in the form of stock options rather than cash. The options were granted to the Reporting Person pursuant to the Issuer's Amended & Restated Non-Employee Director Compensation Policy, as amended, in lieu of retainer fees of $14,750 for the quarter ended March 31, 2024.
F2	Fully vested as of the date of grant.

Content

This stock option was granted in connection with the Reporting Person's election to receive the Reporting Person's quarterly retainer for director services in the form of stock options rather than cash. The options were granted to the Reporting Person pursuant to the Issuer's Amended & Restated Non-Employee Director Compensation Policy, as amended, in lieu of retainer fees of $14,750 for the quarter ended March 31, 2024.

Fully vested as of the date of grant.